|
|
|
|
||||||||||
|
ChiRhoClin, Inc., a Maryland based corporation, was founded in 1991 by CEO, Edward D. Purich, Ph.D. ChiRhoClin is a research and development oriented pharmaceutical company focused on the development of peptide and protein based drug products.
ChiRhoClin, Inc. mission is to provide
high-quality peptide and protein-based drug products for the
Gastrointestinal and Radiological community. Our continuing mission
is to develop orphan drug products that will aid, treat, and diagnose
Gastrointestinal diseases. ChiRhoClin, Inc also provides contract services to the pharmaceutical industry in areas including regulatory support, clinical and medical monitoring, report writing, safety surveillance, pharmacokinetics, pharmacodynamics and biostatistics.
ChiRhoClin, Inc. received approval from the FDA on April 5th, 2002 to manufacture and market Synthetic Porcine Secretin. Two years later, ChiRhoClin received approval from the FDA on April 9th, 2004 to manufacture and market ChiRhoStim (Synthetic Human Secretin for injection).
Contact Information
ChiRhoClin, Inc. 4000 Blackburn Lane, Suite 270 Burtonsville MD, 20866 301-476-8388 Fax: 301-476-9529 Email: ChiRhoClin@ChiRhoClin.com
|
|
||||||||||
|